Steven Cohen's INDV Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 94,943 shares of Indivior Pharmaceuticals, Inc. (INDV) worth $2.89 M, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in INDV for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 1.69 M shares. Largest reduction occurred in Q1 2026, reducing 1.73 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Indivior Pharmaceuticals (INDV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Indivior Pharmaceuticals (INDV) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.73 M | Reduce 94.79% | 94,943 | $30.48 |
| Q4 2025 | -1.04 M | Reduce 36.36% | 1.82 M | $35.88 |
| Q3 2025 | -710,284 | Reduce 19.88% | 2.86 M | $24.11 |
| Q2 2025 | +1.69 M | Add 89.42% | 3.57 M | $14.74 |
| Q1 2025 | +1.89 M | New Buy | 1.89 M | $9.53 |
Steven Cohen's Indivior Pharmaceuticals Investment FAQs
Steven Cohen first purchased Indivior Pharmaceuticals, Inc. (INDV) in Q1 2025, acquiring 1,886,231 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Indivior Pharmaceuticals, Inc. (INDV) for 5 quarters since Q1 2025.
Steven Cohen's largest addition to Indivior Pharmaceuticals, Inc. (INDV) was in Q1 2025, adding 1,886,231 shares worth $17.98 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 94,943 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $2.89 M.
As of the Q1 2026 filing, Indivior Pharmaceuticals, Inc. (INDV) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Indivior Pharmaceuticals, Inc. (INDV) was 3,572,859 shares, as reported at the end of Q2 2025.